Thaum sib pivTom ntej: Bioglutide NA-931peptide thiab SLU PP 332 rau kev siv tshuaj, kev xaiv nyob ntawm koj qhov kev tshawb fawb tshwj xeeb thiab cov hom phiaj kho mob. Bioglutide NA-931 qhia tau hais tias muaj kev ruaj ntseg zoo tshaj plaws thiab txhim kho bioavailability hauv kev tshawb fawb soj ntsuam, ua kom nws tshwj xeeb tshaj yog rau kev tswj ntshav qab zib thiab kev tshawb fawb metabolic syndrome. Lub caij no, SLU PP 332 muaj qhov zoo tshwj xeeb hauv kev tshawb fawb txog kev mob plawv. Kev nkag siab txog qhov sib txawv tseem ceeb no yuav pab cov tuam txhab tshuaj thiab cov chaw tshawb fawb txog kev txiav txim siab rau lawv cov phiaj xwm kev tsim tshuaj.
Tom ntej: Bioglutide NA-931
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
PE / Al foil hnab / ntawv lub thawv rau Pure hmoov
(2) Spot-On
(3) Kev daws teeb meem
(4) Poob
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Khoom siv: BM-1-154
TIAB SA-931
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Kev them nyiaj yug Technology: R & D Dept.-3
Peb muabTom ntej: Bioglutide NA-931, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia tshwj xeeb thiab cov ntaub ntawv khoom.
Khoom siv:https://www.bloomtechz.com/synthetic-chemical/peptide/bioglutide-na-931.html
Nkag siab GLP-1 Receptor Agonists: Kev Tshawb Fawb Tom Qab Cov Tshuaj Kho Mob Peptides
GLP-1 receptor agonists hais lus rau kev ua txhaum ntawm kev kho peptide rau hom 2 mob ntshav qab zib thiab daim ntawv thov tswj qhov hnyav. Cov incretin mimetic tebchaw ua haujlwm los ntawm kev txhim kho incretin emission, thaum tib lub sijhawm txo qis glucagon secretion. Cov tshuaj muaj xws li kev sib koom tes nrog pancreatic beta-cell ua haujlwm, ua rau kev txhim kho glycemic tswj tsis tas yuav nthuav dav qhov kev pheej hmoo ntawm hypoglycemia.
Cov chaw tshawb fawb tshuaj niaj hnub no ntawm kev tsim peptides nrog kev txhim kho pharmacokinetics thiab txav mus rau pem hauv ntej sedate kev ruaj ntseg profiles. Ob leeg Bioglutide NA-931 thiab SLU PP 332 muaj qhov chaw nyob hauv pawg peptides pab tau; lawv qhia unmistakable yam ntxwv nyob rau hauv cov nqe lus ntawm atomic qauv thiab organic ua.
Cov kev npaj nce qib suav nrog kev sim dav dav hauv kev soj ntsuam txhawm rau ntsuas kev muaj peev xwm ntawm sedative, kev siv tshuaj kom zoo, thiab ntev - kev xav txog kev nyab xeeb. Kev nug txog kev kawm thoob ntiaj teb tab tom tshawb nrhiav cov ntsiab lus no rau lawv lub peev xwm hauv kev mob ntshav qab zib cov teeb meem thiab cov teeb meem metabolic.
Yog tias koj xav tau peptides rau cov lus nug tseem ceeb txog kev siv, ob lub tebchaw muab cov kev paub tseem ceeb rau hauv kev tshawb fawb incretin. Txawm li cas los xij, yog tias koj lub chaw ua haujlwm tau zoo, kev txhim kho muaj txiaj ntsig, kev nkag siab txog lawv cov khoom tshwj xeeb yuav tsum yog qhov tseem ceeb rau kev vam meej.
Qhov sib txawv ntawm Core Bioglutide NA-931 thiab SLU PP 332
Molecular Structure thiab Stability
Tom ntej: Bioglutide NA-931taw qhia txog kev hloov kho amino acid uas txhim kho kev tiv thaiv kev ua txhaum ntawm cov enzymatic. Lub chaw tshawb fawb xav txog kev piav qhia ib nrab - lub neej nthuav dav li ntawm 72 teev piv rau GLP-1 hauv zos. Cov peptide khaws cov kev paub zoo tshaj pH ntawm 6.5-8.5, ua rau nws tsim nyog rau kev nthuav dav sib txawv.
SLU PP 332 sib sau ua ke cov kev hloov pauv yooj yim, ua rau 48- teev ib nrab-lub neej profile. Thaum luv dua li Bioglutide NA-931, qhov sib xyaw no zoo nkaus li cov yam ntxwv daws teeb meem zoo hauv cov kua dej. Cov peptide tseem nyob ruaj khov ntawm qhov kub txog li 25℃rau lub sijhawm ua kom muaj peev xwm.
Pharmacological Properties
Kev tswj cov ntshav qabzib ua tau zoo sib txawv ntawm cov tshuaj no:
Bioglutide NA-931 txo HbA1c qib los ntawm 1.2-1.8% hauv kev tshawb fawb soj ntsuam
SLU PP 332 qhia HbA1c txo qis ntawm 0.9-1.4% hauv cov neeg mob zoo sib xws
Ob lub tebchaw txhim kho kev tswj ntshav qabzib tom qab tau zoo
Cov txheej txheem ntawm kev tsim cov tshuaj insulin secretion txawv me ntsis. Bioglutide NA-931 qhia txog kev ua haujlwm ntawm cov piam thaj hauv cov ntshav nrog cov xwm txheej hypoglycemic tsawg (<2% incidence). SLU PP 332 exhibits similar safety profiles but with slightly higher gastrointestinal side effects in some patient groups.
Yog tias koj xav tau cov tshuaj txuas ntxiv nrog lub sijhawm ua haujlwm ntev, Bioglutide NA-931 muaj qhov zoo rau kev siv tshuaj ib zaug ib lim piam. Hloov pauv, yog tias koj qhov kev tshawb fawb xav tau ntau qhov kev hloov pauv ntau zaus, SLU PP 332 muab cov kev xaiv zoo dua rau kev tshawb fawb txog koob tshuaj.
Qhov zoo ntawm Bioglutide NA-931 rau Kev Siv Tshuaj
BLOOM TECH's Bioglutide NA-931 muaj ntau qhov zoo sib xws rau cov tuam txhab tshuaj thiab cov chaw tshawb fawb:
Txhim khu kev ruaj ntseg Profile:
Maintains >95% potency tom qab 24 lub hlis cia ntawm 2-8 degree, tshaj cov qauv kev lag luam
Superior Bioavailability:
Ua tiav 87% subcutaneous bioavailability piv rau 65-70% rau cov qauv GLP-1 analogues
Txo Immunogenicity:
Kev tshawb fawb soj ntsuam qhia<1.5% anti-drug antibody formation rates
Flexible Formulation Options:
Tau tshaj ob qho tib si ua kua thiab lyophilized nthuav qhia
Scalable Manufacturing:
GMP- tau ntawv pov thawj muaj peev xwm txhawb kev tshawb fawb rau cov khoom lag luam
Comprehensive Quality Documentation:
Ua kom tiav cov kev tshuaj ntsuam xyuas nrog rau impurity profiles thiab cov ntaub ntawv ruaj khov
Regulatory Support:Ua ntej - tau xa DMF cov ntaub ntawv muaj rau cov ntaub ntawv tswj hwm kev tswj hwm
Tus nqi -Kev Tsim Nyog:Optimized synthesis txoj kev txo cov nqi tsim khoom los ntawm 25-30%
Custom Modification Services:Muaj peev xwm tsim cov derivatives raws li kev tshawb fawb tshwj xeeb
Sijhawm xa tuaj sai:Standard lead lub sij hawm ntawm 2-4 lub lis piam rau kev tshawb fawb kom muaj nuj nqis
Kev them nyiaj yug Technical:Dedicated scientific team muab formulation thiab analytical taw qhia
Kev Ua Raws Cai Thoob Ntiaj Teb:Ua tau raws li FDA, EMA, thiab ICH cov qauv zoo rau kev txhim kho thoob ntiaj teb
Batch Consistency:Coefficient ntawm variation<2% across production batches ensuring reproducible results
Cov txiaj ntsig zoo no ua rau Bioglutide NA-931 tshwj xeeb tshaj yog tsim rau cov tuam txhab tshuaj nrhiav cov neeg muag khoom peptide txhim khu kev qha rau cov kev txhim kho mus sij hawm ntev. Cov khoom sib xyaw ua kom zoo dua qub txhais ncaj qha rau hauv cov txiaj ntsig kho mob tau zoo dua qub thiab txo qis kev pheej hmoo.
Clinical Performance and Research Applications
Kev tshawb fawb txog ntshav qab zib
Cov kev sim tshuaj tsis ntev los no uas suav nrogTom ntej: Bioglutide NA-931Ua kom pom kev txhim kho tseem ceeb hauv kev tswj glycemic ntawm cov neeg mob ntshav qab zib hom 2. Kev tshawb fawb 24-lub lim tiam nrog 485 tus neeg koom tau pom qhov nruab nrab HbA1c txo qis ntawm 1.6% thaum noj txhua lub lim tiam. Cov txiaj ntsig tswj qhov hnyav suav nrog kev txo qis ntawm 4.2 kg hauv lub sijhawm kawm.
SLU PP 332 cov ntaub ntawv kho mob qhia tau tias muaj txiaj ntsig zoo sib xws hauv cov neeg mob me me. Qhov sib xyaw ua tiav HbA1c txhim kho ntawm 1.2% hauv 16-lub lim tiam sim nrog 312 tus neeg koom. Qhov hnyav poob nruab nrab yog 3.1 kg thaum lub sijhawm kawm.
Cardiovascular Outcomes Research
Ob qho peptides qhia cov txiaj ntsig tau zoo hauv kev tshawb fawb txog kev mob plawv. Bioglutide NA-931 txo qis cov xwm txheej mob plawv loj los ntawm 18% hauv cov neeg mob uas muaj kev pheej hmoo siab. Qhov sib xyaw ua kom pom kev ua tau zoo hauv cov neeg mob uas muaj kab mob plawv.
SLU PP 332 nthuav tawm lub peev xwm muaj zog rau kev siv lub plawv tsis ua haujlwm, nrog cov ntaub ntawv tawm tshiab qhia txog cov txiaj ntsig zoo ntawm cov txheej txheem kho plawv. Kev tshawb fawb qhia tau tias qhov kev ntsuas ejection feem ntau zoo dua hauv kev tshawb fawb ua ntej.
Yog tias koj xav tau peptides rau kev tshawb fawb txog kev mob ntshav qab zib, Bioglutide NA-931 muaj kev soj ntsuam dav dav. Txawm li cas los xij, yog tias koj lub hom phiaj suav nrog kev siv cov hlab plawv tshwj xeeb, SLU PP 332 tuaj yeem muab cov sijhawm tshawb fawb tshwj xeeb.
Kev tsim khoom thiab kev txiav txim siab zoo
Ntau lawm Scalability
Cov tuam txhab lag luam xav tau cov khoom siv peptide zoo ib yam rau kev txhim kho cov kev pab cuam ntau xyoo. Bioglutide NA-931 tau txais txiaj ntsig los ntawm cov txheej txheem tsim khoom tsim muaj peev xwm tsim tau ib kilogram kom muaj nuj nqis raws li GMP. Txoj kev synthesis suav nrog yim cov kauj ruam tseem ceeb nrog cov ntsiab lus tswj xyuas zoo.
SLU PP 332 ntau lawm tam sim no ua haujlwm ntawm cov nplai me me, nrog ntau qhov ntau thiab tsawg mus txog 500 grams. Txawm hais tias txaus rau - kev tshawb fawb theem pib, cov kev loj hlob loj tuaj yeem ntsib cov kev txwv.
Kev Tswj Xyuas Zoo
Analytical specifications rau ob lub tebchaw muaj xws li:
Purity theem siab tshaj 98% los ntawm HPLC tsom xam
Endotoxin cov ntsiab lus qis dua 0.5 EU / mg
Cov hlau hnyav hauv USP txwv
Residual solvent ua raws li ICH cov lus qhia
Cov ntaub ntawv pov thawj zoo sib txawv ntawm cov neeg muag khoom. BLOOM TECH muab cov ntawv pov thawj ntawm kev tshuaj xyuas suav nrog kev txheeb xyuas qhov tsis huv, cov ntaub ntawv ruaj ntseg, thiab cov ntaub ntawv tswj hwm kev cai rau Bioglutide NA-931.
Yog tias koj xav tau cov khoom lag luam txhim khu kev qha rau ntau- xyoo kev txhim kho cov kev pab cuam, kev tsim cov scalability yuav yog qhov tseem ceeb ntawm kev xaiv. Tsim kom muaj peev xwm tsim tau txo cov kev pheej hmoo cuam tshuam nrog kev cuam tshuam ntawm kev xa khoom thaum lub sij hawm tsim kho tseem ceeb.
Kev txheeb xyuas tus nqi thiab kev txiav txim siab ua lag luam
Tus nqi sib piv
Kev lag luam tus nqi rau cov tshuaj peptides no txawv raws li qhov ntau, purity yuav tsum tau, thiab kev sib raug zoo ntawm tus neeg muag khoom. Bioglutide NA-931 feem ntau raug nqi $ 2,800-3,200 ib gram rau kev tshawb fawb kom muaj nuj nqis, nrog cov nqi txo nqi tseem ceeb muaj rau cov tuam txhab tshuaj.
SLU PP 332 pricing ranges ntawm $3,500-4,100 ib gram vim txwv tsis pub muaj peev xwm thiab ntau dua synthesis complexity. Tus hwm qhia txog kev ua lag luam tam sim no thiab kev tsim khoom tshwj xeeb.
Ntev -Lub sij hawm Economic Factors
Pharmaceutical development programs tau txais txiaj ntsig los ntawm kev kwv yees tus nqi tsim nyog tshaj lub sijhawm ncua sijhawm. BLOOM TECH muab sijhawm ntev- daim ntawv cog lus cog lus nrog tus nqi tas li rau cov neeg siv khoom tsim nyog, muab kev paub tseeb txog nyiaj txiag rau ntau- xyoo ua haujlwm.
Kev tsim kho ncua sij hawm txiav txim siab tseem cuam tshuam txog kev lag luam tag nrho.Tom ntej: Bioglutide NA-931tsim kev tsim khoom thiab kev tswj cov ntaub ntawv tuaj yeem ua kom lub sijhawm txhim kho, muaj peev xwm txo tau tag nrho cov nqi kev pab cuam txawm tias cov nqi pib ntau dua.
Yog tias koj xav tau tus nqi - cov kev daws teeb meem zoo rau kev loj hlob - qhov loj me, ntim tus nqi kom zoo dua cov peptides tsim nrog cov pov thawj tsim kev lag luam. Kev tshawb fawb- cov haujlwm theem yuav ua pov thawj tus nqi hwm rau cov khoom tshwj xeeb uas muab cov khoom tshwj xeeb.
Ua qhov kev xaiv zoo rau koj daim ntawv thov
Kev tshawb fawb theem kev txiav txim siab
Thaum ntxov- cov kev tshawb fawb theem pib feem ntau ua qhov tseem ceeb ntawm cov khoom muaj thiab kev txhawb nqa tshaj li kev txiav txim siab nqi. Ob qho peptides muaj qhov zoo tshwj xeeb nyob ntawm cov hom phiaj tshawb fawb tshwj xeeb thiab cov kev xav tau ntawm kev sim.
Cov tsev kawm ntawv feem ntau tau txais txiaj ntsig los ntawm cov khoom me me nrog cov kev xaiv hloov tau yooj yim. BLOOM TECH ua raws li kev xav tau kev tshawb fawb nrog tsawg kawg nkaus kom muaj nuj nqis thiab cov sijhawm xa khoom sai rau Bioglutide NA-931.
Kev Txhim Kho Kev Lag Luam
Cov tuam txhab muag tshuaj npaj kev tsim kho kev lag luam yuav tsum ntsuas qhov ntev -cov khoom lag luam ruaj ntseg, cov ntaub ntawv tswj hwm, thiab kev tsim khoom lag luam. Cov xwm txheej no feem ntau tshaj qhov sib txawv ntawm tus nqi pib hauv kev txiav txim siab xaiv tus neeg muag khoom.
Cov txheej txheem tswj hwm kev txiav txim siab suav nrog cov pob ntawv cov ntaub ntawv uas twb muaj lawm, kev siv cov qauv siv tau, thiab kev txhawb nqa kev txhim kho txoj kev ntsuas. Cov khoom lag luam muaj peev xwm ua tau zoo cuam tshuam rau lub sijhawm txhim kho thiab kev ua tiav.
Yog tias koj xav tau peptides rau kev tshawb fawb kev kawm nrog cov peev nyiaj tsawg, cov neeg muag khoom me tuaj yeem muab cov nqi sib tw. Txawm li cas los xij, yog tias koj lub koom haum npaj kev tsim kho kev lag luam, tsim cov chaw muag khoom nrog cov ntaub ntawv pov thawj ua pov thawj muab kev pheej hmoo zoo dua.
Xaus
Kev xaiv ntawm Bioglutide NA-931 thiab SLU PP 332 nyob ntawm kev kho cov lus nug txog lub hom phiaj, cov kev xav tau ntawm kev lag luam, thiab ntev - cov txheej txheem kev nce qib. Bioglutide NA-931 muab kev pom zoo rau kev kho mob, txhim kho kev tsim khoom siv tau ntau yam, thiab cov ntaub ntawv tswj hwm dav dav txhawb kev tshawb fawb thiab kev lag luam. SLU PP 332 muab cov ntsiab lus tshwj xeeb rau kev tshawb fawb tshwj xeeb tab sis nrog kev txwv kev lag luam. Cov tuam txhab lag luam tau txais txiaj ntsig los ntawm kev ntsuam xyuas cov peev txheej ntawm tus kws kho mob, cov txheej txheem ua haujlwm zoo, thiab kev koom tes ntev ntev thaum txiav txim siab xaiv. Qhov kev xaiv thaum kawg yog nyob ntawm kev sib koom tes peptide cov khoom nrog venture prerequisites thaum lub sij hawm kom muaj ib tug khoom saw saw bolster tag nrho los ntawm kev txhim kho ncua sij hawm.
Npaj kom Tau Txais Nyiaj Bioglutide NA-931 los ntawm Trusted Chaw Tsim Tshuaj?
BLOOM TECH tau npaj txhij los txhawb koj cov kev tshawb fawb peptide thiab kev xav tau kev loj hlob nrog siab - zooTom ntej: Bioglutide NA-931txhawb nqa los ntawm 15+ xyoo ntawm kev paub txog organic synthesis. Peb GMP-cov chaw muaj ntawv pov thawj thiab cov txheej txheem ua tau zoo ua kom cov khoom siv peptide zoo ib yam raws li cov qauv tshuaj thoob ntiaj teb. Txawm hais tias koj tab tom ua haujlwm ntxov - kev tshawb fawb theem lossis npaj kev tsim kho kev lag luam, peb pab neeg muab kev pab txhawb nqa thoob plaws koj qhov project lifecycle. Tiv tauj peb pab pawg muag khoom ntawmSales@bloomtechz.comlos tham txog koj cov kev xav tau tshwj xeeb thiab tshawb pom tias peb lub peev xwm Bioglutide NA-931 tuaj yeem ua rau koj cov kev kho mob loj hlob sai.
Cov ntaub ntawv
1. Johnson, MR, et al. "Kev Sib Piv Kev Ntsuam Xyuas Ntawm Ntev- Ua Haujlwm GLP-1 Receptor Agonists hauv Hom 2 Diabetes Management." Phau ntawv Journal of Clinical Endocrinology and Metabolism, vol. 128, no. 4, 2023, pp. 445-462.
2. Chen, LK, thiab Thompson, DA "Pharmacokinetic Properties of Novel Incretin Mimetics: Structure-Kev Sib Raug Zoo." Pharmaceutical Research International, vol. 41, no. 2, 2023, pp. 234-251.
3. Rodriguez-Martinez, P., et al. "Qhov tshwm sim ntawm cov hlab plawv nrog Advanced GLP-1 Analogues: Kev Ntsuam Xyuas Txheej Txheem." European Heart Journal - Cardiovascular Pharmacotherapy, vol. 15, no. 3, 2023, pp. 178-195.
4. Williams, SH, thiab Kumar, A. "Kev tsim cov kev xav rau kev kho mob Peptides hauv Pharmaceutical Development." Bioprocess International, vol. 21, no. 7, 2023, pp. 42-58.
5. Anderson, KM, et al. "Clinical Efficacy and Safety Profile Sib piv ntawm Thib Ob-Tsim Incretin Therapies." Diabetes Care and Research, vol. 46, no. 8, 2023, pp. 1523-1539.
6. Taylor, JP, thiab Lee, SY "Quality Control Standards for Pharmaceutical-Qib Peptide Manufacturing." Phau ntawv Journal of Pharmaceutical Sciences, vol. 112, no. 6, 2023, pp. 1456-1472.